Further, we used xenograft mouse model to show that Bcl6 in cancer cell has mild effect on tumor growth in immune-deficient mice, but could prominently increase tumor progression in immune-competent mice, suggesting a role of Bcl6 in cancer immune evasion (Figs. 2, 4). Here, BCL6 is linked to cancer.